Elutia Inc. $ELUT Position Increased by AIGH Capital Management LLC

AIGH Capital Management LLC grew its holdings in shares of Elutia Inc. (NASDAQ:ELUT) by 17.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,595,250 shares of the company’s stock after purchasing an additional 527,065 shares during the period. Elutia accounts for 0.5% of AIGH Capital Management LLC’s portfolio, making the stock its 27th biggest position. AIGH Capital Management LLC owned approximately 8.40% of Elutia worth $3,775,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ELUT. Knollwood Investment Advisory LLC boosted its holdings in shares of Elutia by 147.8% in the 4th quarter. Knollwood Investment Advisory LLC now owns 2,556,724 shares of the company’s stock valued at $1,771,000 after buying an additional 1,525,157 shares during the period. Deerfield Management Company L.P. acquired a new stake in Elutia during the third quarter worth about $1,221,000. XTX Topco Ltd acquired a new stake in Elutia during the fourth quarter worth about $71,000. Renaissance Technologies LLC lifted its holdings in Elutia by 64.7% in the fourth quarter. Renaissance Technologies LLC now owns 102,116 shares of the company’s stock worth $71,000 after acquiring an additional 40,123 shares during the last quarter. Finally, Citadel Advisors LLC bought a new position in Elutia in the third quarter worth about $50,000. 74.03% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Wall Street Zen raised Elutia from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Weiss Ratings raised Elutia from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $6.00.

Elutia Stock Performance

Elutia stock opened at $0.97 on Thursday. Elutia Inc. has a one year low of $0.50 and a one year high of $2.64. The company has a 50-day simple moving average of $1.03 and a 200-day simple moving average of $1.00. The firm has a market capitalization of $41.71 million, a P/E ratio of 1.13 and a beta of 0.85.

Elutia (NASDAQ:ELUT) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.02). The company had revenue of $3.11 million for the quarter, compared to analysts’ expectations of $3.00 million.

About Elutia

Elutia, Inc is a biopharmaceutical company focused on the development of novel nitric oxide therapies based on its proprietary polymeric nitric oxide platform. This technology is designed to enable sustained, controlled release of nitric oxide to targeted tissues, potentially overcoming the delivery challenges associated with gaseous nitric oxide and small‐molecule donors.

The company’s lead program is in preclinical development for pulmonary arterial hypertension, with additional research efforts aimed at other cardiovascular and respiratory conditions.